Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-de-la-vie/genome-engineering-via-crispr-cas9-system/descriptif_4208544
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4208544

Genome Engineering via CRISPR-Cas9 System

Langue : Anglais

Coordonnateurs : Singh Vijai, Dhar Pawan K.

Couverture de l’ouvrage Genome Engineering via CRISPR-Cas9 System

Genome Engineering via CRISPR-Cas9 Systems presents a compilation of chapters from eminent scientists from across the globe who have established expertise in working with CRISPR-Cas9 systems. Currently, targeted genome engineering is a key technology for basic science, biomedical and industrial applications due to the relative simplicity to which they can be designed, used and applied. However, it is not easy to find relevant information gathered in a single source. The book contains a wide range of applications of CRISPR in research of bacteria, virus, algae, plant and mammalian and also discusses the modeling of drosophila, zebra fish and protozoan, among others.

Other topics covered include diagnosis, sensor and therapeutic applications, as well as ethical and regulatory issues. This book is a valuable source not only for beginners in genome engineering, but also researchers, clinicians, stakeholders, policy makers, and practitioners interested in the potential of CRISPR-Cas9 in several fields.

1. An introduction to genome editing CRISPR-Cas systems2. Evolution and mechanism of CRISPR-Cas9 systems3. Exploring the potential of CRISPR-Cas9 for removal of human viruses4. Programmable removal of bacterial pathogens using CRISPR-Cas9 system5. Targeted genome editing using CRISPR-Cas9 system in fungi6. CRISPR-Cas9 system for fungi genome engineering towards industrial applications7. Development and challenges of using CRISPR-Cas9 system in mammalians8. CRISPR technology for cell line development and engineering9. Exploring the potential of genome editing CRISPR-Cas9 system in cancer 10. CRISPR-Cas9 for therapy: the challenges and ways to overcome them11. Engineered Cas9 nucleases12. The current progress of CRISPR/Cas9 development in plants13. Fruit crops improvement using CRISPR-Cas9 system14. CRISPR-Cas9 engineered viral immunity in plants15. Genome engineering in medicinally important plants using CRISPR/Cas9 tool16. Genome editing of algal species by CRISPR Cas9 for biofuels17. Development and use of CRISPR in industrial applications18. CRISPR interference based gene silencing in bacteria: Advantages and limitations19. Genome engineering in insects: focus on the CRISPR/Cas9 system20. Recent Progress of CRISPR- Cas9 in Zebra Fish21. CRISPR: a revolutionary tool for genome engineering in the protozoan parasites22. Biosafety, biosecurity, patents, and regulatory issues

Researchers in genome engineering, synthetic biology, metabolic engineering

Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.


Prof. Pawan K. Dhar is the Dean, School of Biotechnology, Jawaharlal Nehru University, New Delhi and heads an active synthetic biology group. Prior to t
  • Provides basic understanding and a clear picture on how to design, use and implement the CRISPR-Cas9 system in different organisms
  • Explains how to create an animal model for disease research and screening purposes using CRISPR
  • Discusses the application of CRISPR-Cas9 systems in basic sciences, biomedicine, virology, bacteriology, molecular biology, neurology, cancer, industry, and many more

Date de parution :

Ouvrage de 384 p.

21.4x27.6 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

170,55 €

Ajouter au panier

Ces ouvrages sont susceptibles de vous intéresser


Genome Editing
105,49 €